These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34852086)

  • 1. Vaccines in Brazil: historical analysis of the Sanitary registration and vaccine availability in the Brazilian Unified Health System.
    Peres KC; Buendgens FB; Prates EA; Bonetti NR; Soares L; Vargas-Peláez CM; Farias MR
    Cien Saude Colet; 2021 Nov; 26(11):5509-5522. PubMed ID: 34852086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
    Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
    Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to vaccines in Brazil and the global dynamics of the Health Economic-Industrial Complex.
    Gadelha CAG; Braga PSDC; Montenegro KBM; Cesário BB
    Cad Saude Publica; 2020; 36 Suppl 2():e00154519. PubMed ID: 32876097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for neglected and emerging diseases in Brazil by 2030: the "valley of death" and opportunities for RD&I in Vaccinology 4.0.
    Homma A; Freire MDS; Possas C
    Cad Saude Publica; 2020; 36Suppl 2(Suppl 2):e00128819. PubMed ID: 33111747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Protagonism of the Brazilian Health Regulatory System in the Evolution of Patient Safety in the Country: History, Dilemmas, and Current Challenges.
    Santana HT; Costa MMM; Nogueira MDSP; Dos Santos ACRB; Carvalho AA; Morelo LT; Ribeiro CFM; de Sousa FC; de Moura HLCA; Barros LS; de Oliveira LSC; Gonçalves MRS
    J Patient Saf; 2020 Dec; 16(4):e260-e266. PubMed ID: 32084092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
    Queiroz NSF; Teixeira FV; Freire CCF; Motta MP; Vasconcellos MAM; Chebli LA; Saad-Hossne R;
    Arq Gastroenterol; 2021; 58(1):1-4. PubMed ID: 33909805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 on immunization of Brazilian infants.
    Alves JG; Figueiroa JN; Urquia ML
    Int J Infect Dis; 2021 Jun; 107():252-253. PubMed ID: 33962080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines: From Public Health to Big Business.
    Guimarães R
    Cien Saude Colet; 2021 May; 26(5):1847-1852. PubMed ID: 34076125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The health economic-industrial complex: production and innovation for universal health access, Brazil.
    Gadelha CA; Maretto G; Nascimento MA; Kamia F
    Bull World Health Organ; 2024 May; 102(5):352-356. PubMed ID: 38680461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vaccine registration on disease prophylaxis: a systematic review.
    Rosa SSRF; da Silva AKA; Dos Santos CR; Silva MDS; Perillo ALP; Mendonça AF; Rosa MFF; Sampaio TL; Carneiro MLB; Rocha JCT; Piratelli-Filho A; de Oliveira AL
    Biomed Eng Online; 2022 Dec; 21(1):84. PubMed ID: 36463207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 vaccination campaign in Brazil and the invisibility of science evidences.
    Maciel E; Fernandez M; Calife K; Garrett D; Domingues C; Kerr L; Dalcolmo M
    Cien Saude Colet; 2022 Mar; 27(3):951-956. PubMed ID: 35293472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Public Health Events on COVID-19 Vaccine Hesitancy on Chinese Social Media: National Infoveillance Study.
    Zhang Z; Feng G; Xu J; Zhang Y; Li J; Huang J; Akinwunmi B; Zhang CJP; Ming WK
    JMIR Public Health Surveill; 2021 Nov; 7(11):e32936. PubMed ID: 34591782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of COVID-19 on vaccination coverage in Brazil.
    Silveira MM; Conrad NL; Leivas Leite FP
    J Med Microbiol; 2021 Nov; 70(11):. PubMed ID: 34845982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Child health vulnerabilities during the COVID-19 pandemic in Brazil and Portugal.
    Cabral IE; Pestana-Santos M; Ciuffo LL; Nunes YDR; Lomba MLLF
    Rev Lat Am Enfermagem; 2021 Jul; 29():e3422. PubMed ID: 34231787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 vaccines, where do we stand?
    Fischer A
    C R Biol; 2021 Jun; 344(1):43-55. PubMed ID: 34213848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.